TECHNOLOGY SUMMARY

DNA sequencing and RNA therapeutics have revolutionized the medical and biodefense worlds but sequencing proteins that underpin cellular pathogenicity remains slow and expensive. Glyphic Bio's single-molecule protein sequencing platform identifies all proteins in a sample to enable rapid diagnosis of known diseases and the detection of novel, emerging threats

AREA/MATURITY/AWARDS

Primary Application Area: Medical Devices & Materials

Technology Development Status: Prototype

Technology Readiness Level: TRL 4

SHOWCASE SUMMARY

Organization Type: Mid-stage Startup (A or B)

Website: https://glyphic.bio/

MARKET KEYWORDS

Market Keywords: public health crises, novel threats, central lab